Biotech · Private company
Mendus
Track this companyFree. Adds Mendus to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Intuvax (INN: ilixadencel)Phase 2 · Renal Cell Carcinoma, MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- SunitinibPhase 2 · Renal Cell Carcinoma, MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- ilixadencelPhase 1 · Carcinoma, Squamous Cell of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Carcinoma, Squamous Cell of Head and NeckClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced CancerPHASE1 · TERMINATED · started Jan 14, 2019ClinicalTrials.gov NCT03735290 · fetched Nov 12, 2026
- Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)PHASE2 · COMPLETED · started Apr 1, 2015ClinicalTrials.gov NCT02432846 · fetched Nov 12, 2026